Detalhe da pesquisa
1.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029412
2.
Simultaneous Exposure to Intracellular and Extracellular Photosensitizers for the Treatment of Staphylococcus aureus Infections.
Antimicrob Agents Chemother
; 65(12): e0091921, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516248
3.
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.
Am J Hematol
; 93(4): 486-493, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266344
4.
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
J Clin Oncol
; 42(11): 1288-1300, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301187
5.
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.
Nat Med
; 29(9): 2278-2285, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592104
6.
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
J Cancer Res Clin Oncol
; 149(15): 14125-14136, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552307
7.
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
J Clin Oncol
; 41(2): 186-197, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166727
8.
Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250417
9.
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
J Med Chem
; 63(11): 6179-6202, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32390431
10.
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
J Med Chem
; 62(7): 3475-3502, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852885
11.
Extracellular polymeric substance (EPS)-degrading enzymes reduce staphylococcal surface attachment and biocide resistance on pig skin in vivo.
PLoS One
; 13(10): e0205526, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30304066
12.
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice.
PLoS One
; 11(4): e0152968, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27046148
13.
Factor XI as a target for antithrombotic therapy.
Drug Discov Today
; 19(9): 1454-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886766